Valued at $37.0M at its later-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Watch Solarea Bio: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Solarea Bio funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $9.9M | ▮ | ▮ |
| Aug 2024 | Seed Round | $1.0M | ▮ | ▮ |
| May 2023 | Later Stage VC (Series B) | $15.0M | ▮ | ▮ |
| Sep 2020 | Early Stage VC (Series A) | $11.3M | ▮ | ▮ |
Membership and data by Private Market View
Solarea Bio valuation
Solarea Bio was valued at $37 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Solarea Bio raised?
Solarea Bio has raised $37.4 million across 4 recorded rounds since 2020. The largest was a $9.9 million early-stage round in Nov 2025.
Solarea Bio has filed 4 Form Ds with the SEC since 2020, most recently in Nov 2025 ($9.9 million sold to 5 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Hinge Bio ($46 million), ParcelBio ($41.2 million) and Persephone Biosciences ($37.3 million).
How Solarea Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Solarea Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Solarea Bio
- What is Solarea Bio worth?
- Solarea Bio is valued at $37.0M as of Oct 2026. Valued at $37.0M at its later-stage round, Nov 2025. Nothing has traded since.
- How much has Solarea Bio raised?
- Solarea Bio has raised $37.4M in total funding across 4 recorded rounds.
- When did Solarea Bio last raise?
- Solarea Bio last raised in Nov 2025 (Early Stage VC), raising $9.9M.